Nuvectis Pharma (NVCT): 10% owner bought ~$80K
Mosseri Marlio Charles, 10% owner at Nuvectis Pharma, bought ~$80K of Nuvectis Pharma shares.
- ~$80K
- Approx. value · 17K sh @ $4.70
- 2.64M
- Holds after · shares reported
- Traded
- Dec 13, 2024
- Filed
- Dec 16, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 7, 2024InsiderOfficer sold ~$22K of NVCT shares in the open market
- Nov 15, 2024InsiderCEO purchased ~$98K of NVCT shares in the open market
- Nov 19, 2024InsiderOfficer purchased ~$10K of NVCT shares in the open market
- Dec 12, 2024Insider10% owner purchased ~$149K of NVCT shares in the open market
- Dec 13, 2024 · this disclosureInsider10% owner purchased ~$80K of NVCT shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Nuvectis Pharma
OQRO holds no insider, Congress, fund or contract record for Nuvectis Pharma dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NVCT page.
Other recent filings by Mosseri Marlio Charles, 10% owner
- SEC Form 4 at Nuvectis Pharma (NVCT)Jun 24, 2025
- SEC Form 4 at Nuvectis Pharma (NVCT)Jun 20, 2025
- SEC Form 4 at Nuvectis Pharma (NVCT)Jun 20, 2025
- SEC Form 4 at Nuvectis Pharma (NVCT)May 13, 2025
- SEC Form 4 at Nuvectis Pharma (NVCT)May 12, 2025
The full history of Mosseri Marlio Charles, 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Nuvectis Pharma (NVCT) insider traded, and how much?
Mosseri Marlio Charles, 10% owner at Nuvectis Pharma, bought ~$80K of Nuvectis Pharma shares. 17K shares at $4.70, open market.
When did it happen, and when was it made public?
Traded: Dec 13, 2024. Filed: Dec 16, 2024. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean NVCT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Nuvectis Pharma
- SEC Form 13F-HRAug 14, 2026
- SEC Form 4Jun 24, 2025
- SEC Form 4Jun 20, 2025
- SEC Form 4Jun 20, 2025
- SEC Form 4May 13, 2025
- SEC Form 4May 12, 2025
Everything OQRO holds on this company is on its NVCT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
